ALLMedicine™ Bacterial Vaginosis Center
Research & Reviews 1,117 results
https://doi.org/10.1080/01443615.2022.2106555
Journal of Obstetrics and Gynaecology : the Journal of Th... Aranha C, Goriwale M et. al.
Aug 4th, 2022 - Reproductive tract infections (RTIs) such as vaginal candidiasis and bacterial vaginosis (BV) are common among sexually active women and can be both symptomatic or asymptomatic. The microbiota of the reproductive tract triggers immune response at ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351251
Microbiome Anton L, Ferguson B et. al.
Aug 4th, 2022 - The cervicovaginal (CV) microbiome is highly associated with vaginal health and disease in both pregnant and nonpregnant individuals. An overabundance of Gardnerella vaginalis (G. vaginalis) in the CV space is commonly associated with adverse repr...
https://clinicaltrials.gov/ct2/show/NCT05330091
Aug 3rd, 2022 - This decentralized observational study is designed to understand the effects of daily consumption of once daily woman's probiotic (ODWP) on vaginal pH levels in healthy female populations ages 19-70 years of age across the United States. Participa...
https://clinicaltrials.gov/ct2/show/NCT03310853
Aug 1st, 2022 - Throughout pregnancy women undergo many biological changes, including alterations in their microbiota. These infections can exacerbate pregnancy complications and increase the risk of preeclampsia and preterm birth. The present study aims to evalu...
https://doi.org/10.1186/s12985-022-01850-x
Virology Journal; Li H, Xiao Z et. al.
Jul 30th, 2022 - HPV (human papillomavirus) is an important cause of cervical cancer. Cervical-vaginal infection with pathogens, such as herpes simplex virus (HSV), bacterial vaginosis Trichomonas vaginalis and vaginal candidiasis could be a cofactor. This study a...
Guidelines 8 results
https://doi.org/10.1001/jama.2020.2684
JAMA , Owens DK et. al.
Apr 8th, 2020 - Bacterial vaginosis is common and is caused by a disruption of the microbiological environment in the lower genital tract. In the US, reported prevalence of bacterial vaginosis among pregnant women ranges from 5.8% to 19.3% and is higher in some r...
https://doi.org/10.1016/j.jogc.2017.04.018
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Yudin MH, Money DM
Jul 22nd, 2017 - To review the evidence and provide recommendations on screening for and management of bacterial vaginosis in pregnancy. The clinical practice options considered in formulating the guideline. Outcomes evaluated include antibiotic treatment efficacy...
https://doi.org/10.1016/S1701-2163(15)30180-8
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Fleming N, O'Driscoll T et. al.
Oct 17th, 2015 - To describe the needs and evidence-based practice specific to care of the pregnant adolescent in Canada, including special populations. Healthy pregnancies for adolescent women in Canada, with culturally sensitive and age-appropriate care to ensur...
https://doi.org/10.1016/S1701-2163(15)30764-7
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Brown R, Gagnon R et. al.
Jan 11th, 2014 - The purpose of this guideline is to provide a framework that clinicians can use to determine which women are at greatest risk of having cervical insufficiency and in which set of circumstances a cerclage is of potential value. Published literature...
https://doi.org/10.1258/ijsa.2011.011012
International Journal of STD & AIDS; Sherrard J, Donders G et. al.
Jul 29th, 2011 - Three common infections are associated with vaginal discharge: bacterial vaginosis, trichomoniasis and candidiasis, of which trichomoniasis is a sexually transmitted infection (STI). This guideline covers the presentation and clinical findings of ...
Drugs 47 results see all →
Clinicaltrials.gov 188 results
https://clinicaltrials.gov/ct2/show/NCT05330091
Aug 3rd, 2022 - This decentralized observational study is designed to understand the effects of daily consumption of once daily woman's probiotic (ODWP) on vaginal pH levels in healthy female populations ages 19-70 years of age across the United States. Participa...
https://clinicaltrials.gov/ct2/show/NCT03310853
Aug 1st, 2022 - Throughout pregnancy women undergo many biological changes, including alterations in their microbiota. These infections can exacerbate pregnancy complications and increase the risk of preeclampsia and preterm birth. The present study aims to evalu...
https://clinicaltrials.gov/ct2/show/NCT05278130
Jul 6th, 2022 - Preterm delivery affects 10% of all pregnancies in the United States. This risk is further increased in pregnant women with a history of preterm delivery. There are multiple etiology contributing of preterm labor. Of these, the presence of inflamm...
https://clinicaltrials.gov/ct2/show/NCT05434104
Jun 27th, 2022 - Research Question: Is it feasible to conduct a future trial to investigate if Lactoferrin is an acceptable alternative to oral antibiotics/antifungals for women with bacterial vaginosis or thrush? Background Over 200,000 women are affected by bact...
https://clinicaltrials.gov/ct2/show/NCT02288832
Jun 13th, 2022 - The principal objective is to use a cost-effectiveness study to assess the medical and economic impact of a new strategy for the screening and subsequent treatment of vaginal flora anomalies before the 20th week of gestation- molecular biology tec...
News 136 results
https://www.mdedge.com/obgyn/article/256248/obstetrics/appropriate-antibiotic-selection-12-common-infections-obstetric
Patrick Duff, MD
Jul 13th, 2022 - For the infections we most commonly encounter in obstetric practice, I review in this article the selection of specific antibiotics. I focus on the key pathogens that cause these infections, the most useful diagnostic tests, and the most cost-effe.
https://www.mdedge.com/obgyn/article/251982/gynecology/treatment-bv-trichomoniasis-approved-adolescents
Jake Remaly
Feb 18th, 2022 - The Food and Drug Administration has approved secnidazole for the treatment of bacterial vaginosis (BV) and trichomoniasis in patients aged 12 years and older. The antimicrobial agent, marketed as Solosec, was first approved in 2017 as a treatment.
https://www.medscape.com/viewarticle/968853
Feb 18th, 2022 - The Food and Drug Administration has approved secnidazole for the treatment of bacterial vaginosis (BV) and trichomoniasis in patients aged 12 years and older. The antimicrobial agent, marketed as Solosec, was first approved in 2017 as a treatment...
https://www.medscape.com/viewarticle/967889
Feb 4th, 2022 - Takeaway Participants with recurrent bacterial vaginosis demonstrated a significantly higher treatment response to oral metronidazole than to intravaginal lactic acid gel at 2 weeks, but treatment failure was common in both groups. Metronidazole w...
https://www.mdedge.com/obgyn/article/251245/mixed-topics/infectious-disease-pop-quiz-clinical-challenge-12-obgyn
Emily Susan Edwards, MD, MS, Patrick Duff, MD
Jan 28th, 2022 - What are the best office-based tests for the diagnosis of bacterial vaginosis? Continue to the answer.